The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals
Open accessAbstract
Solid dosage forms of biopharmaceuticals such as therapeutic proteins could provide enhanced bioavailability, improved storage stability, as well as expanded alternatives to parenteral administration. Although numerous drying methods have been used for preparing dried protein powders, choosing a suitable drying technique remains a challenge. In this review, the most frequent drying methods, such as freeze drying, spray drying, spray freeze drying, and supercritical fluid drying, for improving the stability and bioavailability of therapeutic proteins, are discussed. These technologies can prepare protein formulations for different applications as they produce particles with different sizes and morphologies. Proper drying methods are chosen, and the critical process parameters are optimized based on the proposed route of drug administration and the required pharmacokinetics. In an optimized drying procedure, the screening of formulations according to their protein properties is performed to prepare a stable protein formulation for various delivery systems, including pulmonary, nasal, and sustained-release applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmaceutical Particle Engineering via Spray Drying
Vehring, R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9475-1 · Cited by 1,691
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice
Tang, X., & Pikal, M. J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016234.73023.75 · Cited by 972
Antibody Structure, Instability, and Formulation
Wang, W., Singh, S., Zeng, D. L., King, K., & Nema, S. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20727 · Cited by 941
Formulation strategy and use of excipients in pulmonary drug delivery
Pilcer, G., & Amighi, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.017 · Cited by 791
Sosnik, A., & Seremeta, K. P. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.05.003 · Cited by 671
Trojan particles: Large porous carriers of nanoparticles for drug delivery
Tsapis, N., Bennett, D., Jackson, B., Weitz, D. A., & Edwards, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182233999 · Cited by 546
Mensink, M. A., Frijlink, H. W., van der Voort Maarschalk, K., & Hinrichs, W. L. J. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.01.024 · Cited by 492
Protein Inhalation Powders: Spray Drying vs Spray Freeze Drying
Maa, Y.-F., Nguyen, P.-A., Sweeney, T., Shire, S. J., & Hsu, C. C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018828425184 · Cited by 356
Formulation and delivery issues for monoclonal antibody therapeutics
Daugherty, A. L., & Mrsny, R. J. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.011 · Cited by 351
Mechanisms of protein stabilization in the solid state
Chang, L. (., & Pikal, M. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21825 · Cited by 326
Spray Drying of Biopharmaceuticals: Stability and Process Considerations
Ameri, M., & Maa, Y.-F. (2006) · Drying Technology · doi:10.1080/03602550600685275 · Cited by 300
Freeze‐drying of proteins: some emerging concerns
Roy, I., & Gupta, M. N. (2004) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20030133 · Cited by 288
Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects
Skyler, J. S., Weinstock, R. S., Raskin, P., Yale, J.-F., Barrett, E., Gerich, J. E., Gerstein, H. C., & the Inhaled Insulin Phase III Type 1 Diabetes Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1630 · Cited by 269
Al-Qadi, S., Grenha, A., Carrión-Recio, D., Seijo, B., & Remuñán-López, C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.008 · Cited by 265
What is the future of PEGylated therapies?
Swierczewska, M., Lee, K. C., & Lee, S. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1113254 · Cited by 249
Next Generation Drying Technologies for Pharmaceutical Applications
Walters, R. H., Bhatnagar, B. S., Tchessalov, S., Izutsu, K., Tsumoto, K., & Ohtake, S. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23998 · Cited by 235
Quattrin, T., Bélanger, A., Bohannon, N. J. V., Schwartz, S. L., & for the Exubera Phase III Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2622 · Cited by 225
Cleland, J. L., Duenas, E. T., Park, A., Daugherty, A., Kahn, J., Kowalski, J., & Cuthbertson, A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00258-9 · Cited by 222
Pharmaceutical spray freeze drying
Wanning, S., Süverkrüp, R., & Lamprecht, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.053 · Cited by 219
Stabilization of proteins in solid form
Cicerone, M. T., Pikal, M. J., & Qian, K. K. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.006 · Cited by 188
Grenha, A., Remuñán-López, C., Carvalho, E. L. S., & Seijo, B. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.10.017 · Cited by 166
Recent progress in dendrimer-based nanomedicine development
Kim, Y., Park, E. J., & Na, D. H. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1008-4 · Cited by 162
Self-citationSize and Molecular Flexibility of Sugars Determine the Storage Stability of Freeze-Dried Proteins
Tonnis, W. F., Mensink, M. A., de Jager, A., Maarschalk, K. V. D. V., Frijlink, H. W., & Hinrichs, W. L. J. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500423z · Cited by 154
Inhaled proteins: Challenges and perspectives
Depreter, F., Pilcer, G., & Amighi, K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.031 · Cited by 145
Surface modification of lipid-based nanocarriers for cancer cell-specific drug targeting
Kim, C. H., Lee, S. G., Kang, M. J., Lee, S. K., & Choi, Y. W. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0329-5 · Cited by 145
Spray freeze drying for dry powder inhalation of nanoparticles
Ali, M. E., & Lamprecht, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.009 · Cited by 143
Formulation Design of Dry Powders for Inhalation
Weers, J. G., & Miller, D. P. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24574 · Cited by 142
A novel particle engineering technology: spray-freezing into liquid
Rogers, T. L., Hu, J., Yu, Z., Johnston, K. P., & Williams, R. O. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00154-0 · Cited by 141
Rogers, T. L., Johnston, K. P., & Williams, R. O. (2001) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100108363 · Cited by 138
Rogers, T. L., Nelsen, A. C., Hu, J., et al. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00063-2 · Cited by 134
Bittner, B., Morlock, M. M., Koll, H., Winter, G., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00012-5 · Cited by 133
Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability
Costantino, H. R., Firouzabadian, L., Wu, C., Carrasquillo, K. G., Griebenow, K. H., Zale, S. E., & Tracy, M. A. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10059 · Cited by 131
Protein stability in pulmonary drug delivery via nebulization
Hertel, S., Winter, G., & Frieß, W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.003 · Cited by 123
Stabilization of proteins in dry powder formulations using supercritical fluid technology
Jovanović, N., Bouchard, A., Hofland, G. W., Witkamp, G.-J., Crommelin, D. J. A., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000048185.09483.e7 · Cited by 111
Drying technologies for biopharmaceutical applications: Recent developments and future direction
Langford, A., Bhatnagar, B. S., Walters, R. H., Tchessalov, S., & Ohtake, S. (2017) · Drying Technology · doi:10.1080/07373937.2017.1355318 · Cited by 106
Effects of Types of Sugar on the Stabilization of Protein in the Dried State
Imamura, K., Ogawa, T., Sakiyama, T., & Nakanishi, K. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10305 · Cited by 105
Intratracheal delivery of insulin Absorption from solution and aerosol by rat lung
Okumura, K., Iwakawa, S., Yoshida, T., Seki, T., & Komada, F. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90304-k · Cited by 104
Jovanović, N., Bouchard, A., Hofland, G. W., Witkamp, G., Crommelin, D. J. A., & Jiskoot, W. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.003 · Cited by 102
Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination
Garmise, R. J., Staats, H. F., & Hickey, A. J. (2007) · AAPS PharmSciTech · doi:10.1208/pt0804081 · Cited by 101
Inhaled Insulin: A Breath of Fresh Air? A Review of Inhaled Insulin
Cavaiola, T. S., & Edelman, S. V. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.06.025 · Cited by 96
Na, D. H., & DeLuca, P. P. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2589-4 · Cited by 88
Self-citationEnhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former
Yamasaki, K., Kwok, P. C. L., Fukushige, K., Prud’homme, R. K., & Chan, H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.010 · Cited by 87
Analytical approaches to assess the degradation of therapeutic proteins
Filipe, V., Hawe, A., Carpenter, J. F., & Jiskoot, W. (2013) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2013.05.005 · Cited by 82
Technosphere® Insulin: Defining the Role of Technosphere Particles at the Cellular Level
Angelo, R., Rousseau, K., GRANT, M. L., Leone‐Bay, A., & Richardson, P. C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300320 · Cited by 81
Pulmonary insulin delivery by means of the Technosphere™ drug carrier mechanism
Pfützner, A., & Forst, T. M. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.6.1097 · Cited by 79
Cassidy, J., Amin, N., Marino, M. T., Gotfried, M. H., Meyer, T. S., Sommerer, K., & Baughman, R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0443-4 · Cited by 71
Park, H., Ha, D.-H., Ha, E., Kim, J. S., Kim, M., & Hwang, S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11120627 · Cited by 66
Mueannoom, W., Srisongphan, A., Taylor, K. M. G., Hauschild, S., & Gaisford, S. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.09.016 · Cited by 65
Longer action means better drug: Tuning up protein therapeutics
Szlachcic, A., Zakrzewska, M., & Otlewski, J. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.03.005 · Cited by 62
Chiou, H., Chan, H., Heng, D., Prud’homme, R. K., & Raper, J. A. (2008) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2008.02.002 · Cited by 61
Pieters, S., Beer, T. D., Kasper, J. C., Boulpaep, D., Waszkiewicz, O., Goodarzi, M., Tistaert, C., Frieß, W., Remon, J., Vervaet, C., et al. (2011) · Analytical Chemistry · doi:10.1021/ac2022184 · Cited by 50
Mok, H., & Park, T. G. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.04.006 · Cited by 49
Oetjen, G. (2004) · Ullmann's Encyclopedia of Industrial Chemistry · doi:10.1002/14356007.h12_h01 · Cited by 47
Cho, W., Kim, M., Jung, M.-S., Park, J., Cha, K.-H., Kim, J.-S., Park, H. J., Alhalaweh, A., Velaga, S. P., & Hwang, S. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.051 · Cited by 44
Garidel, P., Pevestorf, B., & Bahrenburg, S. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.09.017 · Cited by 43
The stabilization of biopharmaceuticals: current understanding and future perspectives
Song, J. G., Lee, S. H., & Han, H. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0341-9 · Cited by 42
Kumar, V., Sharma, V. K., & Kalonia, D. S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.001 · Cited by 30
Trimeric PEG-Conjugated Exendin-4 for the Treatment of Sepsis
Lee, W., Park, E. J., Kwak, S., Lee, K. C., Na, D. H., & Bae, J. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.5b01756 · Cited by 28
Self-citationTreatment of systemic diseases by inhalation of biomolecule aerosols.
Siekmeier, R., & Scheuch, G. (2009) · PubMed · Cited by 25
Nuchuchua, O., Every, H. A., Hofland, G. W., & Jiskoot, W. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.09.004 · Cited by 24
Nanostructured polysaccharide-based carriers for antimicrobial peptide delivery
Mohtashamian, S., & Boddohi, S. (2016) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0289-1 · Cited by 24
Exendins and exendin analogs for diabetic therapy: a patent review (2012-2015)
Park, E. J., Lim, S. M., Lee, K. C., & Na, D. H. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1192130 · Cited by 22
Self-citationDrying of Biopharmaceuticals: Recent Developments, New Technologies and Future Direction
Langford, A., Bhatnagar, B. S., Walters, R. H., Tchessalov, S., & Ohtake, S. (2018) · Japan Journal of Food Engineering · doi:10.11301/jsfe.18514 · Cited by 19
Inhaled insulin: new formulation, new trial
Bailey, C. J., & Barnett, A. H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60885-9 · Cited by 9
Li, X., Huang, Y., Huang, Z., Ma, X., Dong, N., Chen, W., Pan, X., & Wu, C. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1026-z · Cited by 7
Zadeh, A. H. M., Najafabadi, A. R., Vatanara, A., Faghihi, H., & Gilani, K. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1353520 · Cited by 5
Self-citation
Cited by
Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery
Lengyel, M., Kállai-Szabó, N., Antal, V., Laki, A. J., & Antal, I. (2019) · Scientia Pharmaceutica · doi:10.3390/scipharm87030020 · Cited by 598
Jakubowska, E., & Lulek, J. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102357 · Cited by 83
Tahara, K. (2020) · Advanced Powder Technology · doi:10.1016/j.apt.2019.10.031 · Cited by 31
Metadata
- Authors
- Emami, F., Vatanara, A., Park, E. J., & Na, D. H.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2018-08-17
- Volume
- 10
- Issue
- 3
- Pages
- 131
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W2886457623
- Cited by
- 254
- References
- 67
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.